Obesity is not just about physical appearance, it’s about health and well-being,” writes two-time Olympic medallist Neeraj ...

The WHO report highlights that most cases of colorectal cancer are diagnosed in the later stages when treatment becomes more ...

These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...

Discover why people risk buying Ozempic and similar weight loss medications through social media, the devastating consequences, and legitimate ways to treatment ...

Another of the big complaints grandparents have about this generation of kids that should deeply concern their parents is ...

Welcome to the full-year 2024 Novo Nordisk earnings conference call. [Operator instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over ...

Gov. Ned Lamont eyed Medicaid reimbursement rates, a hospital tax restructuring and pharmaceutical costs in his biennial ...

Studies demonstrate that for every 10% increase in ultra-processed food consumption, the risk of chronic diseases like cancer and diabetes rises by over 10% In addition, these foods have been linked ...

Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.

By Tony Edwards is a former BBC TV producer-director-writer with more than 80 science documentaries to his credit (including ...

The World Health Organisation, WHO, has warned of a rising cancer burden. Breast cancer remains the most common cancer among ...

If you’re a regular reader of this space, you know that the Leader’s editorials, like politicians and the IRS, aren’t always popular. They’re not meant to be. But they are ...